156 related articles for article (PubMed ID: 36734381)
1. Prenatal exposure to valproic acid induces alterations in the expression and activity of purinergic receptors in the embryonic rat brain.
Babiec L; Wilkaniec A; Adamczyk A
Folia Neuropathol; 2022; 60(4):390-402. PubMed ID: 36734381
[TBL] [Abstract][Full Text] [Related]
2. Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism.
Hirsch MM; Deckmann I; Santos-Terra J; Staevie GZ; Fontes-Dutra M; Carello-Collar G; Körbes-Rockenbach M; Brum Schwingel G; Bauer-Negrini G; Rabelo B; Gonçalves MCB; Corrêa-Velloso J; Naaldijk Y; Castillo ARG; Schneider T; Bambini-Junior V; Ulrich H; Gottfried C
Neuropharmacology; 2020 May; 167():107930. PubMed ID: 31904357
[TBL] [Abstract][Full Text] [Related]
3. Alterations of Purinergic Receptors Levels and Their Involvement in the Glial Cell Morphology in a Pre-Clinical Model of Autism Spectrum Disorders.
Babiec L; Wilkaniec A; Matuszewska M; Pałasz E; Cieślik M; Adamczyk A
Brain Sci; 2023 Jul; 13(7):. PubMed ID: 37509018
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
Resende RR; Britto LR; Ulrich H
Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
[TBL] [Abstract][Full Text] [Related]
5. 5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure.
Khodaverdi M; Rahdar M; Davoudi S; Hajisoltani R; Tavassoli Z; Ghasemi Z; Amini AE; Hosseinmardi N; Behzadi G; Janahmadi M
Neurobiol Learn Mem; 2021 Sep; 183():107462. PubMed ID: 34015444
[TBL] [Abstract][Full Text] [Related]
6. Purinergic receptors in embryonic and adult neurogenesis.
Oliveira Á; Illes P; Ulrich H
Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
[TBL] [Abstract][Full Text] [Related]
7. Role of purines in brain development, from neuronal proliferation to synaptic refinement.
Rimbert S; Moreira JB; Xapelli S; Lévi S
Neuropharmacology; 2023 Oct; 237():109640. PubMed ID: 37348675
[TBL] [Abstract][Full Text] [Related]
8. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
9. Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors.
Gomes DA; Song Z; Stevens W; Sladek CD
Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R940-9. PubMed ID: 19625689
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and molecular characterization of functional P2 receptors in rat embryonic cardiomyocytes.
Cheung KK; Marques-da-Silva C; Vairo L; dos Santos DS; Goldenberg R; Coutinho-Silva R; Burnstock G
Purinergic Signal; 2015 Mar; 11(1):127-38. PubMed ID: 25510459
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders.
Gąssowska-Dobrowolska M; Cieślik M; Czapski GA; Jęśko H; Frontczak-Baniewicz M; Gewartowska M; Dominiak A; Polowy R; Filipkowski RK; Babiec L; Adamczyk A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443651
[TBL] [Abstract][Full Text] [Related]
12. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptors in psychiatric disorders.
Krügel U
Neuropharmacology; 2016 May; 104():212-25. PubMed ID: 26518371
[TBL] [Abstract][Full Text] [Related]
14. Neurobiological substrates underlying corpus callosum hypoconnectivity and brain metabolic patterns in the valproic acid rat model of autism spectrum disorder.
Uccelli NA; Codagnone MG; Traetta ME; Levanovich N; Rosato Siri MV; Urrutia L; Falasco G; Vázquez S; Pasquini JM; Reinés AG
J Neurochem; 2021 Oct; 159(1):128-144. PubMed ID: 34081798
[TBL] [Abstract][Full Text] [Related]
15. Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders.
Huang L; Otrokocsi L; Sperlágh B
Brain Res Bull; 2019 Sep; 151():55-64. PubMed ID: 30721770
[TBL] [Abstract][Full Text] [Related]
16. Expression of P2X purinoceptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures.
Cheung KK; Chan WY; Burnstock G
Neuroscience; 2005; 133(4):937-45. PubMed ID: 15964486
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to valproic acid alters the development of excitability in the postnatal rat hippocampus.
Fueta Y; Sekino Y; Yoshida S; Kanda Y; Ueno S
Neurotoxicology; 2018 Mar; 65():1-8. PubMed ID: 29309796
[TBL] [Abstract][Full Text] [Related]
18. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
19. Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X₁, P2X₂, P2X₃ channels, P2Y and A₃ metabotropic receptors in neurotransmission.
Liñán-Rico A; Wunderlich JE; Enneking JT; Tso DR; Grants I; Williams KC; Otey A; Michel K; Schemann M; Needleman B; Harzman A; Christofi FL
Neuropharmacology; 2015 Aug; 95():83-99. PubMed ID: 25724083
[TBL] [Abstract][Full Text] [Related]
20. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Rodrigues RJ; Almeida T; Richardson PJ; Oliveira CR; Cunha RA
J Neurosci; 2005 Jul; 25(27):6286-95. PubMed ID: 16000618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
